ASCO E-Poster: Immune-Related Adverse Events

Immune-related adverse events (AEs) are becoming more frequent in oncology patients receiving immunotherapy. To better understand emerging trends and education needs, the Association of Cancer Care Centers (ACCC) developed the Immuno-Oncology Census as part of its ongoing commitment to sharing up-to-date strategies for managing adverse events. In this episode, CANCER BUZZ speaks with Bat-ami Gordon, clinical research PhD candidate at the Icahn School of Medicine at Mount Sinai, who discusses best practices for cancer care providers to identify immune-related AEs caused by immunotherapy.   "Understanding the best practices for identification is going to be the best way we can start to implement better treatments for these immune-related adverse events." – Bat-ami Gordon   Bat-ami Gordon Clinical Research PhD Candidate  Icahn School of Medicine Mount Sinai New York, NY      Additional Reading/Sources   Icahn School of Medicine at Mount Sinai ACCC Immune-Related Adverse Events Resources Clinical Characteristics and Treatment of Immune-Related Adverse Events of Immune Checkpoint Inhibitors ACCC Immuno-Oncology Census